Neonicotinoids and Mental Health: Mechanistic, Preclinical and Epidemiological Evidence for a Transdiagnostic Neurodevelopmental Risk

Neonicotinoid insecticides (imidacloprid, clothianidin, thiacloprid, acetamiprid, thiamethoxam, nitenpyram, dinotefuran) were developed as insect-selective nicotinic acetylcholine receptor (nAChR) agonists and have long been regarded as safe for vertebrates. However, parent compounds and, more potently, desnitro metabolites such as DN-imidacloprid act on mammalian α4β2 and α7 nAChRs with nicotine-like potency, implicating cholinergic circuits central to cognition, mood, and reward. This narrative review synthesizes mechanistic, preclinical, and epidemiological evidence linking neonicotinoid exposure to neuropsychiatric risk. Mechanistically, these compounds promote glial activation, oxidative stress, blood–brain barrier (BBB) disruption, and gut microbiota alterations that converge on hippocampal and limbic dysfunction. Rodent and invertebrate studies show sex-, dose-, and exposure-window-dependent effects on anxiety-, depression-, and cognition-like behaviors, with developmental exposure mirroring prenatal nicotine effects. Human data, although limited, are convergent: poisoning case series document acute neuropsychiatric symptoms; biomonitoring studies in China, Japan, and Sri Lanka associate urinary metabolites with depression, anxiety, and a recognizable “neo-nicotinic” symptom cluster; in Mexico, studies of agricultural populations link pesticide mixtures to psychological distress, although neonicotinoid biomarkers have not yet been measured in that setting; and pediatric cohorts in China and Ecuador link prenatal and childhood exposure to impaired neurodevelopment, emotional symptoms, and hyperactivity. Collectively, this evidence is consistent with neonicotinoids being an underrecognized environmental risk factor for neuropsychiatric disorders, although the human data remain too fragmented to support causal inference and underscores the need for dedicated cohorts, expanded biomonitoring, and mechanistic research to inform regulatory assessment.

Authors

Institutions

Publication Details

Journal
Toxics
Published
2026-11-19
DOI
https://doi.org/10.3390/toxics14111026
Primary Topic
Pesticide Exposure and Toxicity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Neonicotinoids and Mental Health: Mechanistic, Preclinical and Epidemiological Evidence for a Transdiagnostic Neurodevelopmental Risk

Alejandro David Soriano-Hernández, César Soria-Fregozo, Juan Francisco Rodríguez‐Landa, Gilberto Uriel Rosas-Sánchez et al.
Toxics
Pesticide Exposure and Toxicity
article

Neonicotinoids and Mental Health: Mechanistic, Preclinical and Epidemiological Evidence for a Transdiagnostic Neurodevelopmental Risk

Alejandro David Soriano-Hernández, César Soria-Fregozo, Juan Francisco Rodríguez‐Landa, Gilberto Uriel Rosas-Sánchez, León Jesús Germán-Ponciano, Rafael Fernández-Demeneghi, Mario Eduardo Flores-Soto, M.I. Pérez Vega, Silvia Lizette Ramos de Robles, Santiago Avalos-García, Ena Hazel Ortíz-Sánchez
article en

Abstract

Neonicotinoid insecticides (imidacloprid, clothianidin, thiacloprid, acetamiprid, thiamethoxam, nitenpyram, dinotefuran) were developed as insect-selective nicotinic acetylcholine receptor (nAChR) agonists and have long been regarded as safe for vertebrates. However, parent compounds and, more potently, desnitro metabolites such as DN-imidacloprid act on mammalian α4β2 and α7 nAChRs with nicotine-like potency, implicating cholinergic circuits central to cognition, mood, and reward. This narrative review synthesizes mechanistic, preclinical, and epidemiological evidence linking neonicotinoid exposure to neuropsychiatric risk. Mechanistically, these compounds promote glial activation, oxidative stress, blood–brain barrier (BBB) disruption, and gut microbiota alterations that converge on hippocampal and limbic dysfunction. Rodent and invertebrate studies show sex-, dose-, and exposure-window-dependent effects on anxiety-, depression-, and cognition-like behaviors, with developmental exposure mirroring prenatal nicotine effects. Human data, although limited, are convergent: poisoning case series document acute neuropsychiatric symptoms; biomonitoring studies in China, Japan, and Sri Lanka associate urinary metabolites with depression, anxiety, and a recognizable “neo-nicotinic” symptom cluster; in Mexico, studies of agricultural populations link pesticide mixtures to psychological distress, although neonicotinoid biomarkers have not yet been measured in that setting; and pediatric cohorts in China and Ecuador link prenatal and childhood exposure to impaired neurodevelopment, emotional symptoms, and hyperactivity. Collectively, this evidence is consistent with neonicotinoids being an underrecognized environmental risk factor for neuropsychiatric disorders, although the human data remain too fragmented to support causal inference and underscores the need for dedicated cohorts, expanded biomonitoring, and mechanistic research to inform regulatory assessment.

ToxicsVol. 14(11)
Universidad Veracruzana (MX), Mexican Social Security Institute (MX), Universidad de Guadalajara (MX)
Pesticide Exposure and Toxicity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon